Audio Recap: Switching HIV ART in Pregnancy
Answering the Questions on Considering an ART Switch During Pregnancy

Released: December 19, 2022

Expiration: December 18, 2023

Annette Haberl
Annette Haberl, MD
William R. Short
William R. Short, MD, MPH, FIDSA

Activity

Progress
1
Course Completed

In this episode, Annette Haberl, MD, and William R. Short, MD, MPH, AAHIVS, discuss when to consider an ART switch during pregnancy, including:

  • Current DHHS, EACS, WHO, BHIVA, and German/Austrian guidelines for the use of ARVs in pregnancy
  • What data and recommendations for the use of ARVs during pregnancy are currently missing from the guidelines
  • Available data on newer ARVs in the ARV pregnancy registry
  • Pharmacokinetic data for newer ARVs including BIC/FTC/TAF and LA CAB + RPV in pregnancy
  • Recommendations for 2-drug ART regimens in pregnancy
  • What to do when someone becomes pregnant on a newer ART regimen that is not yet recommended by the guidelines